Nathalie Ganne-Carrié Selected Research

Nathalie Ganne-Carrié Research Topics

Disease

40	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 06/2002
27	Fibrosis (Cirrhosis) 04/2024 - 04/2005
18	Neoplasms (Cancer) 02/2024 - 11/2009
8	Liver Diseases (Liver Disease) 01/2024 - 10/2014
5	Portal Hypertension 05/2024 - 01/2020
5	Infections 01/2018 - 03/2004
4	Cholangiocarcinoma 03/2024 - 09/2022
4	End Stage Liver Disease 10/2023 - 08/2015
4	Hemorrhage 12/2022 - 03/2005
4	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2022 - 03/2006
3	Ascites 10/2022 - 01/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 03/2006
3	Hepatitis C 01/2019 - 03/2004
2	Esophageal and Gastric Varices (Esophageal Varices) 06/2022 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2019
2	Cholestasis 01/2022 - 07/2008
2	Autoimmune Hepatitis 01/2022 - 01/2021
2	Carcinogenesis 01/2022 - 07/2010
2	Hepatic Encephalopathy 01/2021 - 03/2005
2	Inflammation (Inflammations) 01/2019 - 01/2015
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 01/2019
2	Liver Neoplasms (Liver Cancer) 08/2017 - 01/2017
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 04/2024
1	Thrombocytopenia (Thrombopenia) 04/2024
1	Splenomegaly 04/2024
1	Chronic Pain 04/2024
1	Liver Failure 04/2024
1	Neoplasm Metastasis (Metastasis) 03/2024
1	Liver Abscess 02/2024
1	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2023
1	Body Weight Changes 01/2023
1	Thrombosis (Thrombus) 11/2022
1	Frailty 09/2022
1	Chronic Hepatitis C 06/2022
1	Hypercholesterolemia 06/2022
1	Focal Nodular Hyperplasia 01/2022
1	Cholangitis 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Iron Overload 01/2022
1	COVID-19 02/2021
1	Coinfection 01/2021
1	Hepatitis D 01/2021
1	Hydrothorax 01/2020
1	Hepatorenal Syndrome 01/2020

Drug/Important Bio-Agent (IBA)

6	Bevacizumab (Avastin)FDA Link 01/2024 - 12/2022
6	atezolizumabIBA 01/2024 - 12/2022
6	Antiviral Agents (Antivirals)IBA 06/2022 - 05/2007
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2013
3	BilirubinIBA 02/2024 - 08/2015
3	CateninsIBA 01/2023 - 12/2013
3	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2015
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2018 - 11/2009
3	IronIBA 01/2015 - 03/2006
2	LipidsIBA 01/2023 - 01/2015
2	AutoantibodiesIBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2017
2	Epithelial Cell Adhesion MoleculeIBA 10/2018 - 12/2013
2	Oral ContraceptivesIBA 09/2018 - 05/2003
2	Fetal Proteins (Fetoprotein)IBA 01/2017 - 10/2014
2	Peroxidase (Myeloperoxidase)IBA 02/2012 - 11/2009
1	Capsules (Microcapsules)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Keratin-18 (Keratin 18)IBA 10/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	4-(3-chlorophenylsulfanyl)piperidineIBA 10/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	PlatinumIBA 09/2022
1	AlbuminsIBA 06/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022
1	Syndecan-1 (Syndecan 1)IBA 01/2022
1	GlypicansIBA 01/2022
1	Contrast MediaIBA 01/2022
1	SulfatasesIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Hepatitis B e AntigensIBA 01/2021
1	Rifaximin (L 105)FDA Link 01/2021
1	micaIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	AcetaldehydeIBA 01/2019

Therapy/Procedure

16	Radiofrequency Ablation 03/2024 - 02/2009
8	Liver Transplantation 04/2024 - 01/2012
5	Therapeutics 12/2023 - 01/2017
4	Transjugular Intrahepatic Portasystemic Shunt 05/2024 - 01/2020
4	Transplantation 04/2024 - 06/2002
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 09/2022 - 02/2021
1	Operative Surgical Procedures 04/2024
1	Adjuvant Chemotherapy 03/2024
1	Immunotherapy 01/2024
1	Genomic Medicine 12/2023
1	Contraception (Birth Control) 01/2023
1	Aftercare (After-Treatment) 06/2022
1	Stents 10/2021
1	Treatment Delay 02/2021
1	Secondary Prevention 01/2021